ALGN vs. WST: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?
Here's Why Align Technology (ALGN) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Align Technology (ALGN) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Here is how Align Technology (ALGN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Align Technology: Broad-Based Q4 Outperformance Supports Upside
Align Technology delivered a second consecutive strong quarter, with Q4 results significantly exceeding both market and management expectations. ALGN remains undervalued, trading at a discount to sector and historical multiples, supporting a Buy rating and a raised target price of $195 (11% upside). Clear Aligner segment achieved record volumes, while Systems & Services growth and cost discipline drove margin expansion and robust profitability.
Here's Why Align Technology (ALGN) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down
Align Technology shares surge after Q4 EPS and revenues beat expectations, lifted by record Clear Aligner volumes, even as gross and operating margins fall.
Align Technology (ALGN) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates
Align Technology (ALGN) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $2.99 per share. This compares to earnings of $2.44 per share a year ago.
Insights Into Align Technology (ALGN) Q4: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Align Technology (ALGN) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Align Technology (ALGN) Just Flashed Golden Cross Signal: Do You Buy?
After reaching an important support level, Align Technology, Inc. (ALGN) could be a good stock pick from a technical perspective. ALGN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Here's How Align Technology Is Placed Ahead of Q4 Earnings
ALGN heads into Q4 earnings with revenues likely to rise 3.9% and EPS up 22.5%, aided by Clear Aligner demand and scanner growth.
